Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsy

Author： Miyaoka Tsuyoshi   Seno Haruo   Inagaki Takuji   Horiguchi Jun  

Publisher： Ashgate Publishing Ltd

ISSN： 1365-1501

Source： International Journal of Psychiatry in Clinical Practice, Vol.6, Iss.1, 2002-03, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy

By Caparros-Lefebvre D.   Sergeant N.   Lees A.   Camuzat A.   Daniel S.   Lannuzel A.   Brice A.   Tolosa E.   Delacourte A.   Duyckaerts C.  

Brain, Vol. 125, Iss. 4, 2002-04 ,pp. : 801-811

Oxford University Press

Access to resources Recommend Favorite

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

By Williams David R.  

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1247-1258

Oxford University Press

Access to resources Recommend Favorite

Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy

By Lehricy Stphane  

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2410-2425

Oxford University Press

Access to resources Recommend Favorite

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

By Williams David R.  

Brain, Vol. 130, Iss. 6, 2007-06 ,pp. : 1566-1576

Oxford University Press

Access to resources Recommend Favorite

Psychiatric Aspects of Progressive Supranuclear Palsy

By Chiu H.F.K.  

General Hospital Psychiatry, Vol. 17, Iss. 2, 1995-03 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite